April 19, 2018 / 4:27 PM / 3 months ago

BRIEF-Quantum Genomics Presents Its 3-Year Strategic Plan

April 19 (Reuters) - QUANTUM GENOMICS SA:

* PRESENTS ITS 3-YEAR STRATEGIC PLAN.

* ARTERIAL HYPERTENSION: COMPLETION OF NEW-HOPE STUDY BROUGHT FORWARD TO DECEMBER 2018

* HEART FAILURE: EARLY LAUNCH OF A PHASE IIB STUDY IN 4(TH) QUARTER 2018, ON BASIS OF GOOD PRODUCT SAFETY IN HEART FAILURE PATIENTS

* TO SIGN A STRATEGIC PARTNERSHIP OR LICENSE AGREEMENT WITH A PHARMACEUTICAL GROUP WITHIN 24 MONTHS

* JEAN-PHILIPPE MILON NOW ASSUMES POSITION OF CEO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below